共 55 条
Impact of lysophosphatidylcholine on survival and function of UEA-1+acLDL+ endothelial progenitor cells in patients with coronary artery disease
被引:13
作者:
Hong, Seong Hun
[1
]
Jang, Hyun Hee
[1
]
Lee, So Ra
[1
]
Lee, Kyung Hye
[1
]
Woo, Jong Shin
[1
]
Kim, Jin Bae
[1
]
Kim, Woo-Shik
[1
]
Min, Byung Il
[2
,3
]
Cho, Ki Ho
[4
]
Kim, Kwon Sam
[1
]
Cheng, Xianwu
[5
]
Kim, Weon
[1
,2
]
机构:
[1] Kyung Hee Univ, Div Cardiol, Seoul, South Korea
[2] Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Internal Med, Div Cardiovasc, 1 Hoegi Dong, Seoul 130702, South Korea
[3] Kyung Hee Univ, Dept Physiol, Seoul, South Korea
[4] Hosp Korean Med, Dept Cardiovasc & Neurol Dis, Seoul, South Korea
[5] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan
基金:
新加坡国家研究基金会;
关键词:
Lysophosphatidylcholine;
Endothelial progenitor cell;
Pravastatin;
Coronary artery disease;
Vulnerable plaque;
LOW-DENSITY-LIPOPROTEIN;
SMOOTH-MUSCLE-CELLS;
CARDIOVASCULAR EVENTS;
MIGRATORY ACTIVITY;
NUMBER;
APOPTOSIS;
ANGIOGENESIS;
IMPAIRMENT;
ASPIRIN;
ACID;
D O I:
10.1007/s00380-014-0473-z
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Lysophosphatidylcholine (LPC) generated from oxidized low-density lipoprotein by lipoprotein-associated phospholipase A2 plays a key role in plaque inflammation and vulnerability. Endothelial progenitor cells (EPCs) can repair injured endothelium and exert anti-inflammatory effects of vulnerable plaque. We study the impact and mechanisms of LPC on UEA-1 and acLDL binding EPCs (UEA-1(+)acLDL(+) EPCs). UEA-1(+)acLDL(+) EPCs from coronary artery disease (CAD) patients were cultured and exposed to LPC at different concentrations and different timepoints. We determined the significant concentration (40 mu M). UEA-1(+)acLDL(+) EPCs were preincubated for 30 min with pravastatin (20 mu M) with LY249002, a specific inhibitor of the Akt signaling pathway, and exposed for 24 h to LPC 40 mu M. The survival, migration, adhesion, and proliferation of UEA-1(+)acLDL(+) EPCs were assessed. To examine the mechanisms of LPC toxicity and pravastatin effects, phosphorylated Akt and endothelial nitric oxide synthase (eNOS) levels and the ratio of Bcl-2/Bax protein expression were assessed. LPC induced apoptosis and impaired migration and adhesion of UEA-1(+)acLDL(+) EPCs significantly. The detrimental effects of LPC were attenuated by pravastatin. However, when UEA-1(+)acLDL(+) EPCs were pretreated with pravastatin and LY249002, a specific inhibitor of the Akt signaling pathway, simultaneously, the beneficial effects of pravastatin were abolished. Furthermore, LPC suppressed Akt and eNOS phosphorylation and increased Bcl-2/Bax expression. The effects of LPC on Akt/eNOS and Bcl-2/Bax activity were reversed by pravastatin. In conclusion, LPC inhibited UEA-1(+)acLDL(+) EPCs survival and impaired its functions, and these were attributable to inhibition of the Akt/eNOS and Bcl-2/Bax pathway. Pravastatin reversed the detrimental action of LPC. These findings suggest that LPC inhibition can be a possible strategy for CAD through EPC revitalization.
引用
收藏
页码:115 / 125
页数:11
相关论文